Page last updated: 2024-10-26

pentetic acid and Tuberous Sclerosis

pentetic acid has been researched along with Tuberous Sclerosis in 4 studies

Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.

Tuberous Sclerosis: Autosomal dominant neurocutaneous syndrome classically characterized by MENTAL RETARDATION; EPILEPSY; and skin lesions (e.g., adenoma sebaceum and hypomelanotic macules). There is, however, considerable heterogeneity in the neurologic manifestations. It is also associated with cortical tuber and HAMARTOMAS formation throughout the body, especially the heart, kidneys, and eyes. Mutations in two loci TSC1 and TSC2 that encode hamartin and tuberin, respectively, are associated with the disease.

Research Excerpts

ExcerptRelevanceReference
"Findings on cranial magnetic resonance (MR) images were correlated with known histopathologic findings in 42 patients with tuberous sclerosis (TS), 17 of whom received gadopentetate dimeglumine, to extend the range of signs on MR images."8.78MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. ( Altman, NR; Bilaniuk, LT; Braffman, BH; Brody, BA; Naidich, TP; Post, MJ; Quencer, RM; Zimmerman, RA, 1992)
"Findings on cranial magnetic resonance (MR) images were correlated with known histopathologic findings in 42 patients with tuberous sclerosis (TS), 17 of whom received gadopentetate dimeglumine, to extend the range of signs on MR images."4.78MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review. ( Altman, NR; Bilaniuk, LT; Braffman, BH; Brody, BA; Naidich, TP; Post, MJ; Quencer, RM; Zimmerman, RA, 1992)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Muroff, LR1
Runge, VM1
Menor, F1
MartĂ­-BonmatĂ­, L1
Mulas, F1
Poyatos, C1
Cortina, H1
Braffman, BH1
Bilaniuk, LT1
Naidich, TP1
Altman, NR1
Post, MJ1
Quencer, RM1
Zimmerman, RA1
Brody, BA1
Martin, N1
Debussche, C1
De Broucker, T1
Mompoint, D1
Marsault, C1
Nahum, H1

Reviews

2 reviews available for pentetic acid and Tuberous Sclerosis

ArticleYear
The use of MR contrast in neoplastic disease of the brain.
    Topics in magnetic resonance imaging : TMRI, 1995,Summer, Volume: 7, Issue:3

    Topics: Brain; Brain Diseases; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Co

1995
MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentetate dimeglumine, and literature review.
    Radiology, 1992, Volume: 183, Issue:1

    Topics: Adolescent; Adult; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Dru

1992

Other Studies

2 other studies available for pentetic acid and Tuberous Sclerosis

ArticleYear
Neuroimaging in tuberous sclerosis: a clinicoradiological evaluation in pediatric patients.
    Pediatric radiology, 1992, Volume: 22, Issue:7

    Topics: Adolescent; Astrocytoma; Brain Neoplasms; Cerebellar Cortex; Child; Child, Preschool; Contrast Media

1992
Gadolinium-DTPA enhanced MR imaging in tuberous sclerosis.
    Neuroradiology, 1990, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Astrocytoma; Brain Neoplasms; Calculi; Child; Child, Preschool; Female; Gadoliniu

1990